Vmn1r123 Inhibitors refers to a class of chemicals that can indirectly inhibit the function of the Vmn1r123 protein by modulating the signaling pathways associated with this receptor. The Vmn1r123 is a vomeronasal 1 receptor, which functions as a GPCR and is pivotal in detecting pheromones that influence social and reproductive behaviors. The chemicals identified as potential Vmn1r123 inhibitors do not directly bind to or block the receptor but instead affect the receptor's ability to propagate its signal through the cell.
The inhibitors function by altering the activity of molecules that relay signals from the receptor to intracellular effectors. For example, Pertussis Toxin and GDPβS target the G-proteins that are essential for the receptor's signal transduction. By modifying the G-proteins, these inhibitors can prevent the receptor from transmitting its signal, effectively silencing its function. Similarly, other inhibitors like U73122 and BAPTA interfere with downstream signaling molecules such as phospholipase C and intracellular calcium, respectively. These disruptions can prevent the normal response to activation of the Vmn1r123 receptor, leading to an inhibition of its physiological role.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inactivates G-proteins by ADP-ribosylation, inhibiting the GPCR signaling that Vmn1r123 relies upon for function. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Non-selective beta-adrenergic antagonist that can interfere with downstream effects of GPCR signaling pathways, including those of Vmn1r123. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Alpha2-adrenergic receptor antagonist, which can alter the signaling pathway in which Vmn1r123 may be involved. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $68.00 $267.00 | 10 | |
Calcium chelator that can disrupt intracellular calcium levels, affecting GPCR-related signaling pathways of Vmn1r123. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor that disrupts calcium homeostasis, which can impact GPCR-mediated signaling pathways including Vmn1r123. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Antagonist of adenosine receptors that can modulate GPCR signaling cascades, potentially affecting Vmn1r123 activity. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A sc-200402B sc-200402C | 50 mg 500 mg 5 g 10 g | $69.00 $364.00 $2500.00 $4100.00 | 11 | |
D4 dopamine receptor antagonist that can affect GPCR signaling, impacting pathways that Vmn1r123 might use. | ||||||